Annual Shareholders Equity
-$77.19 M
-$77.30 M-69019.64%
31 December 2023
Summary:
Foghorn Therapeutics annual stockholders equity is currently -$77.19 million, with the most recent change of -$77.30 million (-69019.64%) on 31 December 2023. During the last 3 years, it has fallen by -$223.38 million (-152.80%). FHTX annual shareholders equity is now -152.80% below its all-time high of $146.19 million, reached on 31 December 2020.FHTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$28.29 M
-$13.96 M-97.51%
30 September 2024
Summary:
Foghorn Therapeutics quarterly stockholders equity is currently -$28.29 million, with the most recent change of -$13.96 million (-97.51%) on 30 September 2024. Over the past year, it has increased by +$29.10 million (+50.71%). FHTX quarterly shareholders equity is now -119.35% below its all-time high of $146.19 million, reached on 31 December 2020.FHTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10000.0% | +50.7% |
| 3 y3 years | -152.8% | -134.9% |
| 5 y5 years | -96.5% | - |
FHTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -152.8% | at low | -129.2% | +71.0% |
| 5 y | 5 years | -152.8% | +12.3% | -119.3% | +78.8% |
| alltime | all time | -152.8% | +12.3% | -119.3% | +78.8% |
Foghorn Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$28.29 M(+97.5%) |
| June 2024 | - | -$14.32 M(-85.3%) |
| Mar 2024 | - | -$97.49 M(+26.3%) |
| Dec 2023 | -$77.19 M(<-9900.0%) | -$77.19 M(+34.5%) |
| Sept 2023 | - | -$57.39 M(+16.3%) |
| June 2023 | - | -$49.35 M(+100.7%) |
| Mar 2023 | - | -$24.59 M(<-9900.0%) |
| Dec 2022 | $112.00 K | $112.00 K(-99.5%) |
| Sept 2022 | - | $24.32 M(-48.9%) |
| June 2022 | - | $47.63 M(-34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $72.40 M(-25.3%) |
| Dec 2021 | $96.87 M(-33.7%) | $96.87 M(+19.6%) |
| Sept 2021 | - | $80.98 M(-22.3%) |
| June 2021 | - | $104.19 M(-16.8%) |
| Mar 2021 | - | $125.16 M(-14.4%) |
| Dec 2020 | $146.19 M(-266.1%) | $146.19 M(-209.6%) |
| Sept 2020 | - | -$133.32 M(-836.1%) |
| June 2020 | - | $18.11 M(-120.6%) |
| Dec 2019 | -$88.02 M(+124.1%) | -$88.02 M |
| Dec 2018 | -$39.27 M | - |
FAQ
- What is Foghorn Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual shareholders equity year-on-year change?
- What is Foghorn Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly shareholders equity year-on-year change?
What is Foghorn Therapeutics annual stockholders equity?
The current annual shareholders equity of FHTX is -$77.19 M
What is the all time high annual shareholders equity for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual stockholders equity is $146.19 M
What is Foghorn Therapeutics annual shareholders equity year-on-year change?
Over the past year, FHTX annual stockholders equity has changed by -$77.30 M (-69019.64%)
What is Foghorn Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of FHTX is -$28.29 M
What is the all time high quarterly shareholders equity for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly stockholders equity is $146.19 M
What is Foghorn Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, FHTX quarterly stockholders equity has changed by +$29.10 M (+50.71%)